BridgeMD
New treatment option for Ischemic Stroke
Official title Obstructive Sleep Apnea Treatment From Acute to Chronic Phase of Stroke
ClinicalTrials.gov ID: NCT07044830
What this study is testing
- What it's testing
- The study aims to evaluate whether early treatment of obstructive sleep apnea with continuous positive airway pressure in ischemic stroke patients has a favorable effect on functional recovery.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Supratentorial non-lacunar ischemic stroke, including anterior, middle, and posterior cerebral artery territories
- Aged 18 to 80 years
- Symptom onset or symptom recognition to admission \< 12 hours
- NIHSS score ≥ 4 and ≤ 20 at enrollment
- Signed informed consent form obtained from the participant or their legal representative
You likely can't join if
- Prior stroke
- Previous diagnosis of OSA with current CPAP use or previously failed CPAP
- Pre-stroke disability (mRS \> 1)
- Coma or stupor
- Orotracheal intubation
- Clinical instability or severe pre-existing illness (e.g., heart failure, oxygen-dependent COPD, renal or hepatic failure)
See the full eligibility criteria
- Supratentorial non-lacunar ischemic stroke, including anterior, middle, and posterior cerebral artery territories
- Aged 18 to 80 years
- Symptom onset or symptom recognition to admission \< 12 hours
- NIHSS score ≥ 4 and ≤ 20 at enrollment
- Signed informed consent form obtained from the participant or their legal representative
- Prior stroke
- Previous diagnosis of OSA with current CPAP use or previously failed CPAP
- Pre-stroke disability (mRS \> 1)
- Coma or stupor
- Orotracheal intubation
- Clinical instability or severe pre-existing illness (e.g., heart failure, oxygen-dependent COPD, renal or hepatic failure)
- Psychomotor agitation
- High likelihood of neurosurgical intervention within the first 48 hours
- Oxygen therapy \>2 L/min
- Known severe neurological disease (e.g., dementia, Parkinson's disease, multiple sclerosis, or other neurodegenerative conditions)
- Chronic alcohol or drug use with high risk of withdrawal during hospitalization
- Pregnant or suspected pregnant women
- Inability to complete follow-up for any reason
- Any contraindication to CPAP use
The study team makes the final eligibility decision.
Where it's taking place
- Ribeirão Preto, São Paulo, Brazil
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ribeirão Preto, São Paulo, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.